67 related articles for article (PubMed ID: 9918572)
21. Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid.
Kane KF; Langman MJ; Williams GR
Cancer Res; 1996 Feb; 56(3):623-32. PubMed ID: 8564982
[TBL] [Abstract][Full Text] [Related]
22. Drug interactions: lipoxygenase inhibitors interfere with ropivacaine-induced vasoconstriction.
Joo DT; Wong GK
Can J Anaesth; 2009 Apr; 56(4):279-81, 281-3. PubMed ID: 19247737
[No Abstract] [Full Text] [Related]
23. Prostaglandin-independent effects of aspirin on cell cycle and putrescine synthesis in human colon carcinoma cells.
Eklou-Kalonji E; Andriamihaja M; Reinaud P; Mayeur C; Camous S; Robert V; Charpigny G; Blachier F
Can J Physiol Pharmacol; 2003 May; 81(5):443-50. PubMed ID: 12774850
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of cell proliferation and invasion in a human colon cancer cell line by 5-aminosalicylic acid.
Kim YH; Kim MH; Kim BJ; Kim JJ; Chang DK; Son HJ; Rhee PL; Rhee JC
Dig Liver Dis; 2009 May; 41(5):328-37. PubMed ID: 18976971
[TBL] [Abstract][Full Text] [Related]
25. [Sulindac induced apoptosis of HT-29 colon adenocarcinoma cell].
Yang Z; Ouyang Q; Wei Y
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):177-9. PubMed ID: 12515128
[TBL] [Abstract][Full Text] [Related]
26. Serum ropivacaine concentrations and systemic local anesthetic toxicity in trauma patients receiving long-term continuous peripheral nerve block catheters.
Bleckner LL; Bina S; Kwon KH; McKnight G; Dragovich A; Buckenmaier CC
Anesth Analg; 2010 Feb; 110(2):630-4. PubMed ID: 19955504
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of the butanamide derivative S 19812, a new dual inhibitor of cyclooxygenase and lipoxygenase pathways.
Tordjman C; Sauveur F; Droual M; Briss S; Andre N; Bellot I; Deschamps C; Wierzbicki M
Arzneimittelforschung; 2003; 53(11):774-9. PubMed ID: 14677373
[TBL] [Abstract][Full Text] [Related]
28. Conjugated linoleic acid (CLA) inhibits growth of Caco-2 colon cancer cells: possible mediation by oleamide.
Kim EJ; Jun JG; Park HS; Kim SM; Ha YL; Park JH
Anticancer Res; 2002; 22(4):2193-7. PubMed ID: 12174903
[TBL] [Abstract][Full Text] [Related]
29. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
[TBL] [Abstract][Full Text] [Related]
30. Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease.
Schmidt C; Kosché E; Baumeister B; Vetter H
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):865-9. PubMed ID: 8574719
[TBL] [Abstract][Full Text] [Related]
31. A comparison of the pharmacodynamics and pharmacokinetics of bupivacaine, ropivacaine (with epinephrine) and their equal volume mixtures with lidocaine used for femoral and sciatic nerve blocks: a double-blind randomized study.
Cuvillon P; Nouvellon E; Ripart J; Boyer JC; Dehour L; Mahamat A; L'hermite J; Boisson C; Vialles N; Lefrant JY; de La Coussaye JE
Anesth Analg; 2009 Feb; 108(2):641-9. PubMed ID: 19151302
[TBL] [Abstract][Full Text] [Related]
32. CP-66,248, a new anti-inflammatory agent, is a potent inhibitor of leukotriene B4 and prostanoid synthesis in human polymorphonuclear leucocytes in vitro.
Moilanen E; Alanko J; Asmawi MZ; Vapaatalo H
Eicosanoids; 1988; 1(1):35-9. PubMed ID: 2856170
[TBL] [Abstract][Full Text] [Related]
33. Ectopic expression of clusterin/apolipoprotein J or Bcl-2 decreases the sensitivity of HaCaT cells to toxic effects of ropivacaine.
Kontargiris E; Kolettas E; Vadalouca A; Trougakos IP; Gonos ES; Kalfakakou V
Cell Res; 2004 Oct; 14(5):415-22. PubMed ID: 15538973
[TBL] [Abstract][Full Text] [Related]
34. MK-886, a leukotriene biosynthesis inhibitor, induces antiproliferative effects and apoptosis in HL-60 cells.
Dittmann KH; Mayer C; Rodemann HP; Petrides PE; Denzlinger C
Leuk Res; 1998 Jan; 22(1):49-53. PubMed ID: 9585079
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of the ropivacaine-induced increase in intracellular Ca2+ concentration in rat aortic smooth muscle.
Tokinaga Y; Ogawa K; Yu J; Kuriyama T; Minonishi T; Hatano Y
Acta Anaesthesiol Scand; 2007 Oct; 51(9):1155-60. PubMed ID: 17714580
[TBL] [Abstract][Full Text] [Related]
36. Effect of lidocaine and ropivacaine on primary (SW480) and metastatic (SW620) colon cancer cell lines.
Siekmann W; Tina E; Von Sydow AK; Gupta A
Oncol Lett; 2019 Jul; 18(1):395-401. PubMed ID: 31497075
[TBL] [Abstract][Full Text] [Related]
37. Bacterial growth in ropivacaine hydrochloride.
Bátai I; Kerényi M; Falvai J; Szabó G
Anesth Analg; 2002 Mar; 94(3):729-31; table of contents. PubMed ID: 11867406
[TBL] [Abstract][Full Text] [Related]
38. Influence of opioid analgesia type on circulating tumor cells in open colorectal cancer surgery (POACC-1): study protocol for a prospective randomized multicenter controlled trial.
Berta E; Srovnal J; Dytrych P; Bruthans J; Ulrichova J; Prasil P; Vecera L; Gabrhelik T; Tolmaci B; Dusa J; Maca J; Mazancova M; Haiduk F; Kutej M; Ihnat P; Michalek P; Hajduch M
BMC Anesthesiol; 2023 Feb; 23(1):64. PubMed ID: 36855089
[TBL] [Abstract][Full Text] [Related]
39. The Effect of Different Anesthetic Techniques on Proliferation, Apoptosis, and Gene Expression in Colon Cancer Cells: A Pilot In Vitro Study.
Alexa AL; Jurj A; Tomuleasa C; Tigu AB; Hategan RM; Ionescu D
Curr Issues Mol Biol; 2023 Jan; 45(1):738-751. PubMed ID: 36661535
[TBL] [Abstract][Full Text] [Related]
40. A 20-Year Research Trend Analysis of the Influence of Anesthesia on Tumor Prognosis Using Bibliometric Methods.
Luo J; Shi Y; Wang X; Zhang R; Chen S; Yu W; Su D; Tian J
Front Oncol; 2021; 11():683232. PubMed ID: 34458138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
